Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Non Operating Investment Income (2017 - 2020)

Historic Non Operating Investment Income for HealthLynked (HLYK) over the last 4 years, with Q3 2020 value amounting to $12802.0.

  • HealthLynked's Non Operating Investment Income fell 9193.27% to $12802.0 in Q3 2020 from the same period last year, while for Dec 2020 it was $739485.0, marking a year-over-year increase of 1007.16%. This contributed to the annual value of $739485.0 for FY2020, which is 1007.16% up from last year.
  • Per HealthLynked's latest filing, its Non Operating Investment Income stood at $12802.0 for Q3 2020, which was down 9193.27% from -$13672.0 recorded in Q2 2020.
  • In the past 5 years, HealthLynked's Non Operating Investment Income ranged from a high of $740355.0 in Q1 2020 and a low of -$238330.0 during Q3 2018
  • In the last 4 years, HealthLynked's Non Operating Investment Income had a median value of $52786.0 in 2018 and averaged $100702.5.
  • Over the last 5 years, HealthLynked's Non Operating Investment Income had its largest YoY gain of 660685.12% in 2018, and its largest YoY loss of 450373.24% in 2018.
  • Over the past 4 years, HealthLynked's Non Operating Investment Income (Quarter) stood at -$1445.0 in 2017, then soared by 6606.85% to $94024.0 in 2018, then increased by 3.82% to $97617.0 in 2019, then plummeted by 86.89% to $12802.0 in 2020.
  • Its Non Operating Investment Income stands at $12802.0 for Q3 2020, versus -$13672.0 for Q2 2020 and $740355.0 for Q1 2020.